Market News (Page 109) - TendieTensor

Market News Page 109 of 159 • 3,956 articles

IPSIPAY to launch next-generation Crypto Payment Platform

GlobeNewswire Inc. • William D. Corbett

IPSIPAY to launch next-generation Crypto Payment Platform

11/03/2025 09:00 AM • Innovative Payment Solutions, Inc. launched a new Crypto Payment Platform enabling cryptocurrency transactions for online gaming and sportsbook sectors, supporting multiple digital assets with real-time conversion and compliance features.

UNH - Mentioned in context of Dhivya Suryadevara's previous executive role
IPSI - Company is expanding into digital assets, launching innovative payment platform, and positioning itself for growth in emerging financial technologies

#cryptocurrency #digital payments #fintech #online gaming #blockchain

Cogent Biosciences Announces Multiple Presentations at the 67th Annual American Society of Hematology (ASH) Meeting

GlobeNewswire Inc. • Cogent Biosciences

Cogent Biosciences Announces Multiple Presentations at the 67th Annual American Society of Hematology (ASH) Meeting

11/03/2025 09:00 AM • Cogent Biosciences will present data on bezuclastinib for NonAdvanced Systemic Mastocytosis at the ASH annual meeting, highlighting potential disease modification and introducing a new JAK2 V617F mutant-selective inhibitor program.

GPN - Mentioned in context of CFO Paul Todd's previous role
COGT - Company is showcasing promising clinical trial results, announcing new research programs, and expressing confidence in potential breakthrough therapies for systemic mastocytosis and other genetically defined diseases

#bezuclastinib #NonAdvSM #JAK2 #ASH meeting #clinical trials

Nokia and Rohde & Schwarz collaborate on AI-powered 6G receiver to cut costs, accelerate time to market

GlobeNewswire Inc. • Nokia Press Office

Nokia and Rohde & Schwarz collaborate on AI-powered 6G receiver to cut costs, accelerate time to market

11/03/2025 09:00 AM • Nokia and Rohde & Schwarz have developed an AI-powered 6G radio receiver that improves network coverage by using machine learning to compensate for signal distortions, potentially reducing deployment costs and accelerating 6G network rollout.

CLOV - Mentioned as part of Fiserv's strategic small business platform development
NOK - Developing innovative AI technology for future 6G networks, demonstrating technological leadership and potential cost-saving solutions

#6G #AI #wireless technology #network infrastructure #machine learning

Phosphorus Declares Independence from Opaque CPS Security Pricing and Passive Discovery Vendors

GlobeNewswire Inc. • Sonu Shankar

Phosphorus Declares Independence from Opaque CPS Security Pricing and Passive Discovery Vendors

11/03/2025 09:00 AM • Phosphorus Cybersecurity launched an autonomous xIoT security platform with transparent per-device pricing, offering comprehensive device discovery, risk assessment, and remediation capabilities for enterprises struggling with diverse and unmanaged IoT devices.

SIEGY - Mentioned through a quote from a former Siemens Industrial Networks Specialist, with no direct negative or positive implications

#xIoT #cybersecurity #device management #risk assessment #IoT security

JAKKS Pacific and SEGA of America Renew Global Toy Partnership for Sonic the Hedgehog™ Merchandise

GlobeNewswire Inc. • Globe Newswire

JAKKS Pacific and SEGA of America Renew Global Toy Partnership for Sonic the Hedgehog™ Merchandise

11/03/2025 09:00 AM • JAKKS Pacific has renewed its partnership with SEGA for the Sonic the Hedgehog toy collection, extending the collaboration until 2029. The multi-year deal allows JAKKS to continue designing and producing action figures, playsets, and other merchandise for the popular video game franchise.

FpD - Exceeded revenue expectations, demonstrated strong performance in Ford Pro and Ford Blue segments, reduced tariff headwinds, maintained cost discipline, and showed confidence through dividend yield
JAKK - Renewed partnership demonstrates continued success with SEGA, expanding product lines and maintaining global toy partnership

#Sonic the Hedgehog #toy partnership #licensing #merchandise

S&P 500 Eyes Fresh Highs as AI Momentum and Trade Truce Fuel Risk Appetite

Investing.com • Fiona Cincotta

S&P 500 Eyes Fresh Highs as AI Momentum and Trade Truce Fuel Risk Appetite

11/03/2025 08:48 AM • US stocks are rising, driven by AI optimism and a US-China trade truce, with the S&P 500 posting its sixth straight monthly gain. Semiconductor firms and tech companies are expected to provide insights into AI demand, while market attention focuses on upcoming economic data and earnings reports.

PLTR - Rising pre-market, lifted full-year revenue forecast, strong demand for AI-linked services

#AI #trade truce #earnings #S&P 500 #market sentiment #Federal Reserve

Elevation Capital Advisory Loads Up Principal U.S. Mega-Cap ETF Shares in Q3

The Motley Fool • Lawrence Rothman

Elevation Capital Advisory Loads Up Principal U.S. Mega-Cap ETF Shares in Q3

11/03/2025 08:31 AM • Elevation Capital Advisory initiated a new $8.7 million position in the Principal U.S. Mega-Cap ETF during Q3, representing 3.5% of its reported equity assets. The ETF focuses on tracking large U.S. mega-cap companies with concentrated holdings across technology, financial, and communication sectors.

USMC - ETF has outperformed S&P 500 by 2.6 percentage points, with a 20.7% return over the past year and holdings in successful large-cap companies

#ETF #mega-cap #investment #equity #technology stocks

IceCure's Cryoablation System Combined with Radiation Therapy Successfully Treats Non-Small Cell Lung Cancer (NSCLC) with 92% Disease-Specific 5-year Survival

Benzinga • Prnewswire

IceCure's Cryoablation System Combined with Radiation Therapy Successfully Treats Non-Small Cell Lung Cancer (NSCLC) with 92% Disease-Specific 5-year Survival

11/03/2025 08:30 AM • A study published in PLOS One demonstrates that IceCure's Cryoablation System combined with radiation therapy achieved a 92% disease-specific 5-year survival rate for stage I non-small cell lung cancer patients with tumors ≥2 cm.

ICCM - The study showed highly promising results with 92% 5-year disease-specific survival, 74% overall survival rate, and no treatment-related mortality, which significantly validates the company's medical technology and potential market impact

#cryoablation #lung cancer #radiation therapy #medical technology #cancer treatment

SuperCom to Report Third Quarter 2025 Financial Results on November 13, 2025

Benzinga • Prnewswire

SuperCom to Report Third Quarter 2025 Financial Results on November 13, 2025

11/03/2025 08:30 AM • SuperCom, a global provider of secured solutions for e-Government, IoT, and Cybersecurity, will hold a conference call on November 13, 2025, to discuss its third quarter 2025 financial results.

SPCB - The article is a standard financial results announcement without indicating positive or negative performance, presenting a neutral informative tone about the upcoming earnings call

#financial results #conference call #e-Government #IoT #Cybersecurity

TOYO and Voltec Solar Forge Strategic Partnership to Deliver Low-Carbon Solar Solutions Across Europe

Benzinga • Prnewswire

TOYO and Voltec Solar Forge Strategic Partnership to Deliver Low-Carbon Solar Solutions Across Europe

11/03/2025 08:30 AM • TOYO Co., Ltd has entered a strategic partnership with Voltec Solar, a French photovoltaic panel manufacturer, to supply high-performance, low-carbon solar cells in the European market, marking TOYO's expansion into Europe.

TOYO - Company is expanding into European market, establishing a strategic partnership, and demonstrating commitment to global solar technology innovation

#solar solutions #strategic partnership #low-carbon technology #European market #sustainability

2 Healthcare Stocks for Individual Investors With a 30-Year Time Horizon

The Motley Fool • Rachel Warren

2 Healthcare Stocks for Individual Investors With a 30-Year Time Horizon

11/03/2025 08:28 AM • The article highlights two healthcare stocks suitable for long-term investors: Eli Lilly and Intuitive Surgical. Both companies demonstrate strong growth potential, innovative product pipelines, and consistent financial performance in the healthcare sector.

LLY - Strong revenue growth (38% YoY), successful GLP-1 franchise, promising drug pipeline in oncology and neuroscience, consistent dividend history, and strategic manufacturing investments

#healthcare #long-term investing #pharmaceutical #surgical robotics #GLP-1 #medical technology

US Stocks Face Two Short-Term Threats Amid Fed's Cautious Approach, Warn Analysts

Benzinga • Namrata Sen

US Stocks Face Two Short-Term Threats Amid Fed's Cautious Approach, Warn Analysts

11/03/2025 08:27 AM • Morgan Stanley analysts warn of two key risks for US stocks: the Federal Reserve's cautious interest rate policy and potential tariff impacts. Despite strong corporate earnings, market uncertainty remains about future monetary stance.

QQQ - Year-to-date performance is strong (+23.29%), but analysts caution about potential market challenges

#Federal Reserve #interest rates #stock market #corporate earnings #tariffs

NewcelX Provides Business and Strategic Roadmap Update Following Closing of Merger with NLS Pharmaceutics Ltd.

Benzinga • Prnewswire

NewcelX Provides Business and Strategic Roadmap Update Following Closing of Merger with NLS Pharmaceutics Ltd.

11/03/2025 08:25 AM • NewcelX, a Swiss clinical-stage biopharmaceutical company, announced a strategic roadmap update after merging with NLS Pharmaceutics Ltd., focusing on developing cell-based and small-molecule therapies for neurodegenerative and metabolic diseases.

NCEL - Company provided a strategic update and investor presentation, indicating ongoing development of therapeutic platforms without explicitly positive or negative financial indicators

#biotechnology #neurodegenerative diseases #metabolic diseases #clinical trials #stem-cell technologies

Stock Market Today: Dow Jones, Nasdaq Futures Rise After Stellar October Gains— Micron Technology, Palantir, Hims & Hers In Focus (UPDATED)

Benzinga • Rishabh Mishra

Stock Market Today: Dow Jones, Nasdaq Futures Rise After Stellar October Gains— Micron Technology, Palantir, Hims & Hers In Focus (UPDATED)

11/03/2025 08:22 AM • U.S. stock futures advanced on Monday following strong October gains, with markets anticipating potential Federal Reserve interest rate cuts and focusing on upcoming earnings reports from several key companies.

MU - Jumped 4.32% in premarket, supported by upbeat memory chip forecast and maintained strong price trends across short, medium, and long terms

#stock market #futures #earnings #Federal Reserve #interest rates

This Dirt Cheap AI Stock Just Announced Its First-Ever Dividend

The Motley Fool • Matt Frankel

This Dirt Cheap AI Stock Just Announced Its First-Ever Dividend

11/03/2025 08:11 AM • PayPal announced its first dividend and highlighted strong AI partnerships with Google and OpenAI, demonstrating potential growth in the fintech and AI sectors with impressive Q3 financial results.

PYPL - Strong Q3 financial performance, new dividend program, strategic AI partnerships, low valuation, and potential for future earnings growth

#PayPal #AI #dividend #fintech #OpenAI #Google

These 2 AI ETFs Are Ready to Crush the S&P 500 Over the Next 10 Years

The Motley Fool • Matt Frankel

These 2 AI ETFs Are Ready to Crush the S&P 500 Over the Next 10 Years

11/03/2025 08:08 AM • The article discusses two AI-focused ETFs that offer different investment strategies: the Invesco QQQ ETF, which provides broad AI exposure through large-cap tech stocks, and the Ark Autonomous Technology & Robotics ETF, which focuses on unique AI and robotics opportunities with an actively managed approach.

QQQ - Low expense ratio (0.20%), broad exposure to top AI companies, represents over 56% of assets in top 10 holdings

#AI #ETF #technology #investing #robotics

Am I the Only One Worried That Apple Hasn't Earned Its Recent Upticks?

The Motley Fool • Rick Munarriz

Am I the Only One Worried That Apple Hasn't Earned Its Recent Upticks?

11/03/2025 08:07 AM • Apple's stock has risen 64% since April, but the company's revenue growth remains slow, with concerns about innovation and sustained growth potential despite hitting new intraday highs.

AAPL - Slow revenue growth (1.8% CAGR over three years), lack of innovation, trading at 33x forward earnings with minimal growth prospects, and potential stagnation after potential short-term growth

#Apple #stock performance #revenue growth #innovation #iPhone #tech stocks

Zscaler Secures The Enterprise AI Lifecycle With Acquisition of Innovative AI Security Pioneer SPLX

Benzinga • Globe Newswire

Zscaler Secures The Enterprise AI Lifecycle With Acquisition of Innovative AI Security Pioneer SPLX

11/03/2025 08:05 AM • Zscaler has acquired AI security company SPLX to enhance its Zero Trust Exchange platform, enabling comprehensive AI lifecycle security with capabilities like AI asset discovery, automated red teaming, and governance.

ZS - Expanding AI security capabilities through strategic acquisition, strengthening market leadership in cloud security

#AI security #zero trust #enterprise security #acquisition #technology

Should You Buy Meta Stock While It's Under $700?

The Motley Fool • Lyle Daly

Should You Buy Meta Stock While It's Under $700?

11/03/2025 08:05 AM • Meta Platforms reported strong Q3 earnings with 26% revenue growth and increased ad performance, but stock dropped due to significant AI infrastructure investments, which investors view with caution.

GEV - Mentioned as a top holding for Thames Capital, but no specific performance details provided
META - Strong ad revenue and AI-driven improvements offset concerns about high capital expenditures on AI infrastructure, resulting in a balanced outlook

#Meta #AI #stock #earnings #advertising #technology

Insurance Arm Steers Loews To Higher Profit With Fewer Catastrophe Losses

Benzinga • Lekha Gupta

Insurance Arm Steers Loews To Higher Profit With Fewer Catastrophe Losses

11/03/2025 08:02 AM • Loews Corporation reported higher Q3 2025 net income of $504 million, driven by strong performance from its insurance arm CNA Financial and improved results across its business segments.

L - Increased net income from $401M to $504M, book value growth, and share repurchases indicate strong financial health

#earnings #insurance #financial performance #stock repurchase

MiddleGround Capital Signs Definitive Agreement to Sell Lindsay Precast

Benzinga • Globe Newswire

MiddleGround Capital Signs Definitive Agreement to Sell Lindsay Precast

11/03/2025 08:01 AM • MiddleGround Capital has entered into a definitive agreement to sell its portfolio company Lindsay Precast to TJC, LP. Lindsay Precast is a leading manufacturer of prefabricated concrete and steel products serving infrastructure needs across various sectors in the United States.

HALO - Mentioned as provider of ENHANZE drug delivery technology used in VYVGART Hytrulo, with no specific performance details discussed
LNN - Expanded capabilities, made strategic acquisitions, and positioned for future growth under new ownership

#private equity #infrastructure #precast concrete #mergers and acquisitions

Milestone Pharmaceuticals to Present New Analysis from Investigational Etripamil Nasal Spray Clinical Trials for PSVT at the American Heart Association Scientific Sessions 2025

GlobeNewswire Inc. • Milestone Pharmaceuticals

Milestone Pharmaceuticals to Present New Analysis from Investigational Etripamil Nasal Spray Clinical Trials for PSVT at the American Heart Association Scientific Sessions 2025

11/03/2025 08:00 AM • Milestone Pharmaceuticals presented clinical trial data for etripamil nasal spray, showing consistent efficacy and safety in treating paroxysmal supraventricular tachycardia (PSVT) across multiple studies, with a New Drug Application currently under FDA review.

PFE - Demonstrated strong innovation with COVID-19 vaccine and antiviral treatment, maintaining leadership in vaccines and infectious disease research
MIST - Presented promising clinical trial results demonstrating consistent efficacy and safety of their lead investigational product, with a pending FDA New Drug Application and potential for a new treatment option in cardiovascular medicine

#etripamil #PSVT #nasal spray #clinical trials #FDA #cardiovascular

AlphaTON Capital Corp Announces Strategic Joint Venture with Pago Pay and with ALT5 Sigma to Launch Crypto-Enabled TON Mastercard

GlobeNewswire Inc. • Brittany Kaiser

AlphaTON Capital Corp Announces Strategic Joint Venture with Pago Pay and with ALT5 Sigma to Launch Crypto-Enabled TON Mastercard

11/03/2025 08:00 AM • AlphaTON Capital has partnered with PagoPay and ALT5 Sigma to launch a Mastercard payment card program enabling native cryptocurrency spending, specifically for TON tokens, with seamless digital wallet integration and global merchant acceptance.

ATON - Company is expanding its ecosystem strategy, gaining exclusive rights to market cryptocurrency cards, and creating potential new revenue streams

#cryptocurrency #Mastercard #TON #digital wallet #blockchain #payment card

Sutro Biopharma Announces Participation at the 16th Annual World ADC Conference

GlobeNewswire Inc. • Sutro Biopharma

Sutro Biopharma Announces Participation at the 16th Annual World ADC Conference

11/03/2025 08:00 AM • Sutro Biopharma will present preclinical data on advanced antibody-drug conjugates (ADCs) at the 16th Annual World ADC Conference, highlighting innovations in dual-payload ADCs and cell-free manufacturing platforms to potentially improve cancer treatment.

COVTY - Listed among competitive market players without specific performance details
STRO - Company is showcasing innovative research, presenting multiple presentations demonstrating technological advancements in ADC development, and emphasizing potential breakthroughs in cancer therapy

#ADCs #oncology #antibody drug conjugates #cancer treatment #preclinical research

SINTX Technologies Announces Launch of OsseoSculpt™ an Advanced Biologic for Use with SINAPTIC® Foot & Ankle Osteotomy Wedge System

GlobeNewswire Inc. • Sintx Technologies

SINTX Technologies Announces Launch of OsseoSculpt™ an Advanced Biologic for Use with SINAPTIC® Foot & Ankle Osteotomy Wedge System

11/03/2025 08:00 AM • SINTX Technologies launched OsseoSculpt™, a next-generation biologic designed to complement its SINAPTIC® Foot & Ankle Osteotomy Wedge System. The company recorded its first commercial revenue in Q3 2025 and plans a broader U.S. rollout through Q4 2025–Q1 2026.

DDw - Recognized as a significant player in developing advanced plastic compounds with potential for innovation
SINT - Company launched a new product, recorded initial commercial revenue, and has a strategic rollout plan for expanding market presence in the medical device sector

#OsseoSculpt #SINAPTIC #biologic #foot and ankle #osteotomy #medical device